Hugo Vicente Miranda

Dikutip oleh

	Semua	Sejak 2020
Kutipan	2512	1519
indeks-h	22	18
indeks-i10	26	25

320

160

240

200720082009201020112012201320142015201620172018201920202021202220232024202510 15 15 19 23 36 56 63 58 81 141 185 264 288 297 315 289 293 37

Akses publik

Lihat semua

20 artikel

1 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Tiago Fleming OuteiroUniversity Medical Center Goettingen, Goettingen, GermanyEmail yang diverifikasi di gwdg.de
Luísa V. LopesPrincipal Investigator, iMM, Faculdade de Medicina, Universidade de LisboaEmail yang diverifikasi di medicina.ulisboa.pt
Ana M SebastiaoFull Professor, Faculty of Medicine, Institute of Molecular Medicine, University of Lisbon, PortugalEmail yang diverifikasi di fm.ul.pt
Eva M. SzegoDept. Neurology, Technische Universität DresdenEmail yang diverifikasi di ukdd.de
Ricardo A GomesiBETEmail yang diverifikasi di ibet.pt
Francisco J. EnguitaFaculdade de Medicina, Universidade de Lisboa, Lisboa, PortugalEmail yang diverifikasi di medicina.ulisboa.pt
Miguel A. R. B. CastanhoBiochemistry, School of Medicine and Institute of Molecular Medicine, University of Lisbon, PortugalEmail yang diverifikasi di medicina.ulisboa.pt
Hilal LashuelEPFLEmail yang diverifikasi di epfl.ch
Luis Fonseca-OrnelasInstructor in Neurology Harvard Medical SchoolEmail yang diverifikasi di bwh.harvard.edu
Jochen KluckenUniversity of Luxembourg, Centre Hospitalier du LuxembourgEmail yang diverifikasi di uni.lu
Luís M. A. OliveiraSenior Associate Director, Michael J Fox Foundation for Parkinson's ResearchEmail yang diverifikasi di michaeljfox.org
Henri G. FranquelimJunior Group Leader, Interfaculty Centre for Bioactive Matter, Leipzig University, GermanyEmail yang diverifikasi di uni-leipzig.de
Sandra TenreiroNova Medical School- Universidade NOVA de Lisboa, Lisbon, PortugalEmail yang diverifikasi di nms.unl.pt
Derek StewartJames Hutton instituteEmail yang diverifikasi di hutton.ac.uk
Omar El-AgnafQatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar FoundationEmail yang diverifikasi di hbku.edu.qa
Eero CastrénNeuroscience Center, University of Helsinki, FinlandEmail yang diverifikasi di helsinki.fi
Nina N. KarpovaUniversity of HelsinkiEmail yang diverifikasi di alumni.helsinki.fi
José RinoGulbenkian Institute for Molecular MedicineEmail yang diverifikasi di gimm.pt
Rodrigo CunhaUniversity of CoimbraEmail yang diverifikasi di fmed.uc.pt
Isabel cordeiro santosC2TN, Sacavem or sacawem or bobadela, Instituto Superior TecnicoEmail yang diverifikasi di ctn.tecnico.ulisboa.pt

Ikuti

Hugo Vicente Miranda

NOVA Medical School (NMS), New University of Lisbon (UNL)

Email yang diverifikasi di nms.unl.pt - Beranda

Neurosciences Dysmetabolism Parkinson's disease Glycation


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation MJ Diógenes, RB Dias, DM Rombo, H Vicente Miranda, F Maiolino, ... Journal of Neuroscience 32 (34), 11750-11762, 2012	313	2012
[alpha]-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B DG Ferreira, M Temido-Ferreira, H Vicente Miranda, VL Batalha, ... Nature Neuroscience, 2017	300	2017
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies H Vicente Miranda, ÉM Szegő, LMA Oliveira, C Breda, E Darendelioglu, ... Brain 140 (5), 1399-1419, 2017	224	2017
The sour side of neurodegenerative disorders: the effects of protein glycation H Vicente Miranda, TF Outeiro The Journal of pathology 221 (1), 13-25, 2010	196	2010
The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease RM de Oliveira, H Vicente Miranda, L Francelle, R Pinho, ÉM Szegö, ... PLoS biology 15 (3), e2000374, 2017	177	2017
Glycation in Parkinson's disease and Alzheimer's disease H Vicente Miranda, OMA El‐Agnaf, TF Outeiro Movement Disorders 31 (6), 782-790, 2016	162	2016
Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose AC Hoffmann, G Minakaki, S Menges, R Salvi, S Savitskiy, A Kazman, ... Scientific reports 9 (1), 544, 2019	149	2019
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease H Vicente Miranda, R Cássio, L Correia-Guedes, MA Gomes, A Chegão, ... Scientific Reports 7 (13713), 2017	112	2017
Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice S Kemppainen, T Rantamäki, A Jerónimo-Santos, G Lavasseur, H Autio, ... Neurobiology of aging 33 (6), 1122. e23-1122. e39, 2012	106	2012
Adenosine A2A receptors modulate α-synuclein aggregation and toxicity DG Ferreira, VL Batalha, H Vicente Miranda, JE Coelho, R Gomes, ... Cerebral Cortex, bhv268, 2015	105	2015
Yeast protein glycation in vivo by methylglyoxal RA Gomes, H Vicente Miranda, MS Silva, G Graça, AV Coelho, ... FEBS Journal 273 (23), 5273-5287, 2006	99	2006
(Poly) phenols protect from α-synuclein toxicity by reducing oxidative stress and promoting autophagy D Macedo, L Tavares, GJ McDougall, H Vicente Miranda, D Stewart, ... Human molecular genetics 24 (6), 1717-1732, 2015	82	2015
Protein glycation in Saccharomyces cerevisiae Argpyrimidine formation and methylglyoxal catabolism RA Gomes, M Sousa Silva, H Vicente Miranda, AEN Ferreira, ... The FEBS journal 272 (17), 4521-4531, 2005	68	2005
Alpha-synuclein glycation and the action of anti-diabetic agents in Parkinson’s disease A König, H Vicente Miranda, TF Outeiro Journal of Parkinson’s disease 8 (1), 33-43, 2018	63	2018
Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases L Sousa, M Guarda, MJ Meneses, MP Macedo, H Vicente Miranda The Journal of pathology 255 (4), 346-361, 2021	50	2021
Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes GR Morais, H Vicente Miranda, IC Santos, I Santos, TF Outeiro, A Paulo Bioorganic & medicinal chemistry 19 (24), 7698-7710, 2011	40	2011
Glycation potentiates neurodegeneration in models of Huntington’s disease H Vicente Miranda, MA Gomes, J Branco-Santos, C Breda, DF Lázaro, ... Scientific Reports 6, 2016	34	2016
Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes A Chegão, M Guarda, BM Alexandre, L Shvachiy, M Temido-Ferreira, ... npj Parkinson's Disease 8 (1), 51, 2022	33	2022
Protein glycation and methylglyoxal metabolism in yeast: finding peptide needles in protein haystacks RA Gomes, H Vicente Miranda, M Sousa Silva, G Graça, AV Coelho, ... FEMS yeast research 8 (1), 174-181, 2008	32	2008
Hsp27 reduces glycation‐induced toxicity and aggregation of alpha‐synuclein. TF Vicente Miranda, H., Chegão, A., Oliveira, M. S., Fernandes Gomes, B ... The FASEB Journal 34 (5), 6718-6728, 2020	29	2020

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama